Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanide. [PDF]
Zhang J +5 more
europepmc +1 more source
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy. [PDF]
Deiman FE +18 more
europepmc +1 more source
Bumetanide‑blocked SLC12A2 exerts a protective effect in experimental diabetic retinopathy. [PDF]
Zhang Y +8 more
europepmc +1 more source
Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial. [PDF]
Costanzo F +17 more
europepmc +1 more source
Treating autism with Bumetanide: Identification of responders using Q-Finder machine learning algorithm. [PDF]
Rabiei H +3 more
europepmc +1 more source
TRPV4 inhibition as a pharmacotherapy for post-hemorrhagic hydrocephalus. [PDF]
Toft-Bertelsen TL, MacAulay N.
europepmc +1 more source
A Case of Steven-Johnson Syndrome Secondary to Bumetanide. [PDF]
Waseem F, Parikh J.
europepmc +1 more source
Chasing the ghost in the code: highlighting the mystery of a rare genetic condition. [PDF]
Delpire E.
europepmc +1 more source
Retrospective Evaluation of Dosing Effects of Bumetanide Continuous Infusions in the Pediatric Cardiac Intensive Care Unit. [PDF]
Narasimhulu SS +13 more
europepmc +1 more source
The Efficacy and Safety of Bumetanide in Children with Autism Spectrum Disorder: An Updated Meta-analysis. [PDF]
Hendi NI +6 more
europepmc +1 more source

